Protagonist Halts Clinical Trial of PTG-100 for UC After Analysis Finds Study Futile
News
A Phase 2b trial of PTG-100, an investigative therapy for moderate-to-severe ulcerative colitis (UC), has been discontinued after an interim analysis deemed the study futile, according to Protagonist Therapeutics. The randomized, ... Read more